Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Kawabata
M
M
Kasuga
S
S
Hara
H
H
Suyama
S
S
Moriyama
K
K
Takabatake
T
T
D000284:Administration, Oral; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002331:Carnitine / Q000008:administration & dosage*; D018450:Disease Progression; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects
D011994:Recombinant Proteins; D004921:Erythropoietin; D002331:Carnitine